Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-273969
Filing Date
2024-12-10
Accepted
2024-12-10 07:38:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d870524d424b3.htm 424B3 118069
2 GRAPHIC g870524g04x04.jpg GRAPHIC 26947
  Complete submission text file 0001193125-24-273969.txt   156488
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-275353 | Film No.: 241537141
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)